- Tel: 858.663.9055
-
Email: info@nsjbio.com
- Tel: 858.663.9055
- Email: info@nsjbio.com
Related Products
|
Programmed death-ligand 1 (PD-L1), encoded by the CD274 gene, is a type I transmembrane immune checkpoint protein belonging to the B7 family of immunoregulatory molecules. PD-L1 Antibody for WB Protein Microarray Validated recognizes this widely studied immune checkpoint ligand, which is commonly referred to as PD-L1, CD274, or B7-H1 in the literature. PD-L1 functions as the primary ligand for the programmed cell death protein 1 (PD-1) receptor expressed on activated T lymphocytes. Engagement of PD-L1 with PD-1 delivers inhibitory signals that suppress T cell proliferation, cytokine production, and cytotoxic activity, thereby helping regulate immune activation and maintain immune tolerance in peripheral tissues.
Western blot analysis is one of the most widely used biochemical approaches for studying PD-L1 expression and post-translational modification. PD-L1 Antibody for WB Protein Microarray Validated is well suited for detecting CD274 protein in cell lysates and tissue extracts where investigators examine immune checkpoint signaling pathways or evaluate PD-L1 expression changes following cytokine stimulation. The PD-L1 protein contains extracellular immunoglobulin-like domains, a single transmembrane region, and a short cytoplasmic tail typical of B7 family ligands. These structural features contribute to its function as a membrane-associated regulatory ligand that controls immune checkpoint signaling through PD-1 receptor engagement.
In western blot experiments, PD-L1 frequently appears as multiple bands because the protein undergoes extensive N-linked glycosylation. The predicted molecular weight of the unglycosylated PD-L1 core protein is approximately 34 kDa, while glycosylated forms commonly migrate between roughly 40 and 70 kDa on SDS-PAGE gels. These higher molecular weight bands reflect glycan modifications that influence PD-L1 stability, trafficking, and receptor interaction. Biochemical studies often confirm the identity of PD-L1 by deglycosylation assays that collapse the higher molecular weight species to the lower molecular weight core protein band. Because of these characteristic migration patterns, western blot analysis provides valuable insight into PD-L1 expression levels as well as its modification state during immune activation or tumor progression studies.
The CD274 gene is located on chromosome 9p24.1 and is strongly regulated by inflammatory signaling pathways. Cytokines such as interferon-gamma activate transcription factors that increase PD-L1 expression in immune cells and epithelial tissues. Many cancers exploit this pathway by increasing PD-L1 expression on tumor cells, allowing them to suppress anti-tumor immune responses and evade immune surveillance. For this reason, CD274 antibody reagents are widely used in research focused on tumor immunology, immune checkpoint signaling, and inflammatory regulation. This mouse monoclonal PD-L1 antibody is validated by protein microarray analysis and is suitable for western blot detection of PD-L1 expression in research applications, and is available from NSJ Bioreagents.
Optimal dilution of the PD-L1 antibody for WB should be determined by the researcher.
A recombinant human partial protein (amino acids 39-191) was used as the immunogen for the protein microarray validated PD-L1 antibody.
Store the PD-L1 antibody at 2-8oC (with azide) or aliquot and store at -20oC or colder (without azide).
Your bulk quote request has been submitted successfully!
Please contact us if you have any questions.